Leading Financial Service Provider in India | Canara Bank Securities Ltd

Alivus Life Sciences Ltd.

Sep 30 BSE 929.35 ( -27.10 -2.83%)

Volume12392

Prev. Close
956.45

Open Price
956.50

Today's Low / High

925.00 956.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

827.10 1259.75

Sep 30 NSE 929.15( -23.15 -2.43%)

Volume97779

Prev. Close
952.30

Open Price
947.55

Today's Low / High

924.50 952.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

850.00 1251.00

Market Cap. ( ₹ in Cr. )	11398.94	P/BV	4.49	Book Value ( ₹ )	206.92
52 Week High/Low ( ₹ )	1251/850	FV/ML	2/1	P/E(X)	23.47
Book Closure	01/09/2025	EPS ( ₹ )	39.58	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1225.37	1225.27	1225.27	1225.27	98.00

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	24.51	24.51	24.51	24.51	1.96
Total Share Capital	24.51	24.51	24.51	24.51	1.96

Reserves and Surplus	2792.87	2307.82	2107.02	2026.31	750.79
Total Reserves and Surplus	2792.87	2307.82	2107.02	2026.31	750.79
Employees Stock Options	0.00	0.00	6.68	3.50	0.00
Total Shareholders Funds	2817.37	2332.32	2138.21	2054.31	752.75

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	54.43	48.79	42.43	31.50	22.89
Other Long Term Liabilities	50.96	14.76	17.09	1.20	0.00
Long Term Provisions	18.54	15.77	0.00	0.00	0.00
Total Non-Current Liabilities	123.92	79.32	59.53	32.70	22.89

CURRENT LIABILITIES
Trade Payables	390.46	368.66	396.56	307.72	221.31
Other Current Liabilities	62.74	58.08	92.32	61.84	980.23
Short Term Provisions	16.96	12.03	15.54	14.44	19.90
Total Current Liabilities	470.16	438.77	504.41	384.00	1221.44

Total Capital And Liabilities	3411.45	2850.41	2702.15	2471.01	1997.08

ASSETS
NON-CURRENT ASSETS
Tangible Assets	942.67	795.01	774.89	584.65	564.89
Intangible Assets	12.28	10.05	5.74	10.38	7.91
Capital Work-In-Progress	94.25	101.19	49.35	91.69	14.10
Intangible Assets Under Development	7.66	4.80	12.26	0.00	0.00
Fixed Assets	1056.86	911.05	842.25	686.72	586.90
Non-Current Investments	0.08	0.08	0.08	0.08	0.08
Other Non-Current Assets	19.36	23.29	9.49	19.63	11.06
Total Non-Current Assets	1076.30	934.41	851.81	706.42	598.03


CURRENT ASSETS
Current Investments	477.62	0.00	0.00	0.00	0.00
Inventories	673.95	666.59	604.17	516.24	513.42
Trade Receivables	969.74	765.43	806.77	673.49	619.50
Cash And Cash Equivalents	71.24	301.59	309.40	512.16	115.60
OtherCurrentAssets	142.62	182.38	130.01	62.69	150.52
Total Current Assets	2335.16	1916.00	1850.34	1764.58	1399.04

Total Assets	3411.45	2850.41	2702.15	2471.01	1997.08

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	37.92	34.20	12.83	50.42	17.23

BONUS DETAILS
Bonus Equity Share Capital	19.60	19.60	19.60	19.60	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.08	0.08	0.08	0.08	0.08

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	477.62	0.00	0.00	0.00	0.00

Markets

Balance Sheet

BALANCE SHEET

Alivus Life Sciences Ltd.